Immunohistochemistry Neuroendocrine Tumor Panel Test sale cost 1170 AED
PML RARA t1517q22q12 Gene Rearrangement Quantitative MRD Monitor Test sale cost 1220 AED PML RARA t1517q22q12 Gene Rearrangement Quantitative MRD Monitor Test Cost 1,350 د.إ Original price was: 1,350 د.إ.1,220 د.إCurrent price is: 1,220 د.إ.
T119 q23p13.3 TCF3-BX1E2A-PBX1 PCR Qualitative Test sale cost 1170 AED T119 q23p13.3 TCF3-BX1E2A-PBX1 PCR Qualitative Test Cost 1,300 د.إ Original price was: 1,300 د.إ.1,170 د.إCurrent price is: 1,170 د.إ.
Sale!

Immunohistochemistry Neuroendocrine Tumor Panel Test Cost

Original price was: 1,300 د.إ.Current price is: 1,170 د.إ.

-10%

The Immunohistochemistry Neuroendocrine Tumor Panel Test is a specialized diagnostic tool used to identify and characterize neuroendocrine tumors (NETs) through the detection of specific markers present in these types of cells. This test utilizes antibodies to target and bind to antigens in the tissues obtained from a patient, providing crucial information about the type, grade, and potential behavior of the tumor. It is an essential component in the management of patients with neuroendocrine tumors, aiding in accurate diagnosis, prognosis, and guiding treatment strategies.

Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test ensures high-quality analysis and reliable results. The cost of the Immunohistochemistry Neuroendocrine Tumor Panel Test is 1170 AED, reflecting the intricate and detailed process involved in detecting the presence and extent of neuroendocrine tumors. This test is particularly valuable for healthcare professionals in making informed decisions about patient care, offering a path towards tailored treatment plans for individuals diagnosed with NETs.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY NEUROENDOCRINE TUMOR PANEL Test

Test Cost: AED 1170.0

Introduction

The immunohistochemistry neuroendocrine tumor panel test is a diagnostic tool used to identify and classify neuroendocrine tumors (NETs) in tissue samples. Neuroendocrine tumors are rare and heterogeneous tumors that arise from neuroendocrine cells, which are found throughout the body and produce hormones. This blog post will provide detailed information about the test, including its components, price, sample condition, report delivery, method, test type, doctor, test department, pre-test information, and test details.

Test Components

  • CDX2
  • Chromogranin
  • Ki67
  • PAX8
  • Synaptophysin
  • TTF1

Price

AED 1170.0

Sample Condition

Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy, and Clinical history.

Report Delivery

  • Sample: Daily by 6 pm
  • Report Block: 5 days
  • Tissue Biopsy: 5 days
  • Tissue large complex: 7 days

Method

Immunohistochemistry

Test Type

Cancer

Doctor

Oncologist, Pathologist

Test Department

HISTOLOGY

Pre Test Information

Provide a copy of the Histopathology report, Site of biopsy, and Clinical history.

Test Details

The immunohistochemistry neuroendocrine tumor panel test is a diagnostic tool used to identify and classify neuroendocrine tumors (NETs) in tissue samples. Neuroendocrine tumors are a group of rare and heterogeneous tumors that arise from neuroendocrine cells, which are found throughout the body and produce hormones. These tumors can occur in various organs, including the lungs, pancreas, gastrointestinal tract, and others.

The immunohistochemistry neuroendocrine tumor panel test involves staining tissue samples with specific antibodies that target proteins commonly expressed in neuroendocrine tumors. These antibodies can help identify and differentiate different types of NETs based on their protein expression patterns. The panel typically includes antibodies against markers such as chromogranin A, synaptophysin, CD56, and neuron-specific enolase (NSE). These markers are commonly expressed in neuroendocrine cells and can help confirm the diagnosis of a neuroendocrine tumor.

The test is performed on tissue samples obtained through a biopsy or surgical resection. The tissue is fixed, processed, and embedded in paraffin, and thin sections are cut for staining. The sections are then incubated with the specific antibodies, and the bound antibodies are visualized using a colorimetric or fluorescent detection system.

The results of the immunohistochemistry neuroendocrine tumor panel test can provide valuable information for the diagnosis, classification, and management of neuroendocrine tumors. It can help differentiate NETs from other types of tumors and determine the origin and grade of the tumor. This information is crucial for guiding treatment decisions and predicting patient outcomes.

Test Name IMMUNOHISTOCHEMISTRY NEUROENDOCRINE TUMOR PANEL Test
Components *CDX2*Chromogranin*Ki67*PAX8 *Synaptophysin*TTF1
Price 1170.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist, Pathologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The immunohistochemistry neuroendocrine tumor panel test is a diagnostic tool used to identify and classify neuroendocrine tumors (NETs) in tissue samples.

Neuroendocrine tumors are a group of rare and heterogeneous tumors that arise from neuroendocrine cells, which are found throughout the body and produce hormones. These tumors can occur in various organs, including the lungs, pancreas, gastrointestinal tract, and others.

The immunohistochemistry neuroendocrine tumor panel test involves staining tissue samples with specific antibodies that target proteins commonly expressed in neuroendocrine tumors. These antibodies can help identify and differentiate different types of NETs based on their protein expression patterns.

The panel typically includes antibodies against markers such as chromogranin A, synaptophysin, CD56, and neuron-specific enolase (NSE). These markers are commonly expressed in neuroendocrine cells and can help confirm the diagnosis of a neuroendocrine tumor.

The test is performed on tissue samples obtained through a biopsy or surgical resection. The tissue is fixed, processed, and embedded in paraffin, and thin sections are cut for staining. The sections are then incubated with the specific antibodies, and the bound antibodies are visualized using a colorimetric or fluorescent detection system.

The results of the immunohistochemistry neuroendocrine tumor panel test can provide valuable information for the diagnosis, classification, and management of neuroendocrine tumors. It can help differentiate NETs from other types of tumors and determine the origin and grade of the tumor. This information is crucial for guiding treatment decisions and predicting patient outcomes.

SKU: TEST-5678 Category:

Related products